| 摘要 |
Disclosed is a pharmaceutical composition comprising Compound 1, (3-(6-(1-(2,2- difluorobenzo[d][1,3]dioxol-5-y1)cyclopropanecarboxamido)-3-methylpyridin-2-y1)benzoic acid), and at least one excipient selected from: a filler, a diluent, a disintegrant, a surfactant, a binder, a glidant and a lubricant, the composition being suitable for oral administration to a patient in need thereof to treat a CFTR mediated disease such as Cystic Fibrosis. |
